These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1421033

  • 1. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases.
    Cooper EH, Forbes MA, Hancock AK, Parker D, Laurence V.
    Biomed Pharmacother; 1992; 46(1):31-6. PubMed ID: 1421033
    [Abstract] [Full Text] [Related]

  • 2. Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinoma.
    Díaz-Martín MA, Traba ML, De La Piedra C, Guerrero R, Méndez-Dávila C, De La Peña EG.
    Scand J Clin Lab Invest; 1999 Apr; 59(2):125-32. PubMed ID: 10353326
    [Abstract] [Full Text] [Related]

  • 3. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
    Morris PG, Fazio M, Farooki A, Estilo C, Mallam D, Conlin A, Patil S, Fleisher M, Cremers S, Huryn J, Hudis CA, Fornier MN.
    J Oral Maxillofac Surg; 2012 Dec; 70(12):2768-75. PubMed ID: 22330331
    [Abstract] [Full Text] [Related]

  • 4. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC, Ku CH, Chao TY, Yu JC, Chen MM, Lee SH.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [Abstract] [Full Text] [Related]

  • 5. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W, Muley T, Herb KP, Schmidt-Gayk H.
    Anticancer Res; 2004 Mar; 24(5B):3193-201. PubMed ID: 15510610
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
    Murphy GP, Troychak MJ, Cobb OE, Bowes VA, Kenny RJ, Barren RJ, Kenny GM, Ragde H, Holmes EH, Wolfert RL.
    Prostate; 1997 Oct 01; 33(2):141-6. PubMed ID: 9316655
    [Abstract] [Full Text] [Related]

  • 7. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
    Body JJ, Dumon JC, Blocklet D, Darte C.
    Eur J Cancer; 1997 Sep 01; 33(10):1578-82. PubMed ID: 9389918
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of alkaline phosphatase and bone-specific alkaline phosphatase for metastases in breast cancer: a systematic review and meta-analysis.
    Jiang C, Hu F, Li J, Gao G, Guo X.
    Breast Cancer Res Treat; 2023 Nov 01; 202(2):233-244. PubMed ID: 37522998
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis.
    Jiang C, Hu F, Xia X, Guo X.
    Int J Biol Markers; 2023 Mar 01; 38(1):25-36. PubMed ID: 36775971
    [Abstract] [Full Text] [Related]

  • 10. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer.
    Reale MG, Santini D, Marchei GG, Manna A, Del Nero A, Bianco V, Marchei P, Frati L.
    Int J Biol Markers; 1995 Mar 01; 10(1):42-6. PubMed ID: 7629426
    [Abstract] [Full Text] [Related]

  • 11. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.
    Beyeler C, Banks R, Thompson D, Forbes MA, Cooper EH, Bird HA.
    J Rheumatol; 1996 Feb 01; 23(2):241-4. PubMed ID: 8882026
    [Abstract] [Full Text] [Related]

  • 12. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
    Ureña P, Prieur P, Pétrover M.
    Presse Med; 1996 Oct 05; 25(29):1320-5. PubMed ID: 8942941
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
    Pectasides D, Farmakis D, Nikolaou M, Kanakis I, Kostopoulou V, Papaconstantinou I, Karamanos NK, Economopoulos T, Raptis SA.
    J Pharm Biomed Anal; 2005 Feb 07; 37(1):171-6. PubMed ID: 15664758
    [Abstract] [Full Text] [Related]

  • 14. Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma.
    Stieber P, Nagel D, Ritzke C, Rössler N, Kirsch CM, Eiermann W, Fateh-Moghadam A.
    Eur J Clin Chem Clin Biochem; 1992 Dec 07; 30(12):809-14. PubMed ID: 1489855
    [Abstract] [Full Text] [Related]

  • 15. Bone alkaline phosphatase in children with chronic renal failure.
    Behnke B, Kemper M, Kruse HP, Müller-Wiefel DE.
    Nephrol Dial Transplant; 1998 Mar 07; 13(3):662-7. PubMed ID: 9550644
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X.
    Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775
    [Abstract] [Full Text] [Related]

  • 17. Serum ostase in the follow-up of breast cancer patients.
    Marchei P, Santini D, Bianco V, Chiodini S, Reale MG, Simeoni F, Marchei GG, Vecchione A.
    Anticancer Res; 1995 Nov 15; 15(5B):2217-22. PubMed ID: 8572628
    [Abstract] [Full Text] [Related]

  • 18. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I, Nikolaou M, Pectasides D, Kiamouris C, Karamanos NK.
    J Pharm Biomed Anal; 2004 Mar 01; 34(4):827-32. PubMed ID: 15019061
    [Abstract] [Full Text] [Related]

  • 19. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
    Schindler F, Lajolo PP, Pinczowski H, Fonseca FL, Barbieri A, Massonetto LH, Katto FT, Del Giglio A.
    Eur J Cancer Care (Engl); 2008 Mar 01; 17(2):152-6. PubMed ID: 18302652
    [Abstract] [Full Text] [Related]

  • 20. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
    Chao TY, Ho CL, Lee SH, Chen MM, Janckila A, Yam LT.
    J Biomed Sci; 2004 Mar 01; 11(4):511-6. PubMed ID: 15153786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.